CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis
CD155/SRC复合物通过抑制p38 MAPK信号通路促进肝细胞癌进展,并与不良预后相关。
期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.794
Jin, An-Li; Zhang, Chun-Yan; Zheng, Wen-Jing; Xian, Jing-Rong; Yang, Wen-Jing; Liu, Te; Chen, Wei; Li, Tong; Wang, Bei-Li; Pan, Bai-Shen; Li, Qian; Cheng, Jian-Wen; Wang, Peng-Xiang; Hu, Bo; Zhou, Jian; Fan, Jia; Yang, Xin-Rong; Guo, Wei
肿瘤
p38 MAPK
肿瘤免疫
CD155
信号转导
SRC
MAPK/ERK
CD15
细胞生物学